Peak Bio, Inc.
NASDAQ: PKBO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hoyoung Huh
- Employees
- 6
- Headquarters
- Palo Alto, United States
- IPO year
- 2021
- Market cap
- $520.3K
- Website
- https://peak-bio.com
Loading PKBO…
Loading profile data…Frequently asked questions about PKBO
What does Peak Bio, Inc. (PKBO) do?
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range...
Where does PKBO trade?
Peak Bio, Inc. (PKBO) trades on the NASDAQ Capital Market.
What sector is PKBO in?
Peak Bio, Inc. (PKBO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Peak Bio, Inc.?
Hoyoung Huh is the chief executive officer of Peak Bio, Inc. (PKBO).
Where is Peak Bio, Inc. headquartered?
Peak Bio, Inc. is headquartered in United States.
Does PKBO pay a dividend?
Peak Bio, Inc. (PKBO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PKBO go public?
Peak Bio, Inc. (PKBO) completed its initial public offering in 2021.